Search

In patients suffering from chronic hepatitis C, Interferon (INF) associated with ribavirin therapy can induce various side effects involving the skin. Our case describes the clinical course of a patient with chronic hepatitis C treated with pegylated α2 INF plus ribavirin. After 6weeks of therapy he developed psoriasis. However, given the progressive improvement of his transaminase levels and viral load decrease, we continued the protocol of the treatment and we started topical calcipotriol/betamethasone dipropionate ointment for psoriasic lesions. After this, the psoriasis improved in a slow but comprehensive manner. This paper suggests that physicians should keep in mind the possibility of the onset of psoriasis as a side effect of INF treatment for chronic hepatitis C.

Bien qu’il ait été montré que le traitement préventif de la thrombose veineuse réduisait la mortalité chez les patients hospitalisés, la plupart des études visant à évaluer les pratiques de thromboprophylaxie (TP) en soulignent la sous-utilisation. La littérature est pauvre en données concernant les pays africains ou arabes [1,2]. Nous avons mené un audit au sein de trois hôpitaux sur les pratiques de cette TP.